Penetration of oral and topical ciprofloxacin into human aqueous humor

Acta Ophthalmologica Scandinavica

Volumn 76, Issue 6, 1998, Pages 683-685

  Çelebi, Serdal ^a,c   Ay, Selma ^a   Aykan, Ümit ^b   Bulut, Vedat ^a   Alagöz, Gürsoy ^a   Çeliker, Ülkü Ö ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b Military Hospital   (Turkey)

^c Faculty of Medicine   (Turkey)

Author keywords

Cataract surgery; Ciprofloxacin; MIC90

Indexed keywords

CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL ARTICLE; DRUG PENETRATION; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PARACENTESIS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TIME; TOPICAL DRUG ADMINISTRATION;

EID: 0031646720     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.1998.760610.x     Document Type: Article

References (16)

1. Alfaro DV, Davis J, Kim S, Bia F, Bogard JF, Briggs JW & Liggett PE (1996): Experimental Bacillus cereus posttraumatic endophthalmitis and treatment with ciprofloxacin. Br J Ophthalmol 80: 755-758.
2. Borrmann LR & Leopold IH (1988): The potential use of quinolones in future ocular antimicrobial therapy. Am J Ophthalmol 106: 227-229.
3. Cokingtin CD & Hyndiuk RA (1991): Insights from experimental data on ciprofloxacin in the treatment of bacterial keratitis and ocular infections. Am J Ophthalmol 112: 25S-28S.
4. Diamond JP, White L, Leeming JP, Hoh HP & Easty DL (1995): Topical 0.3% ciprofloxacin, norfloxacin and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration. Br J Ophthalmol 79: 606-609.
5. Donnenfeld ED, Schrier A, Perry HD, Aulicino T, Gombert ME & Snyder R (1994): Penetration of topically applied ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor. Ophthalmol 101: 902-905.
6. El Baba FZ, Trousdale MD, Gauderman WJ, Wagner DG & Liggett PE (1992): Intravitreal penetration of oral ciprofloxacin in humans. Ophthalmol 99: 483-486.
7. Fern AI, Sweeney G, Doig M & Lindsay G (1986): Penetration of ciprofloxacin into aqueous humor. Trans Ophthalmol Soc UK 105: 650-652.
8. Gantz NM, Brown RB, Bark SL, Espoito AL & Gleckman RA (1994): Postoperative fever. In: Manual of Clinical Problems in Infectious Diseases (Third ed), p 291-295. Little, Brown, Boston.
9. Giarmarellou H, Kanellas D, Kavouklis E, Petrikkos G & Gabriel L (1993): Comparative pharmacokinetics of ciprofloxacin, ofloxacin and perfloxacin in human aqueous humor. Eur J Clin Microbial Infect Dis 12: 293-297.
10. Guzek JP, Chacko D, Kettering JD, Wessels IF & Aprecio RM (1994): Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental pseudomonas aeruginosa keratitis. Cornea 13: 500-504.
11. Kucers A & Bennett NMcK (1987): The use of antibiotics: A Comprehensive Review with Clinical Emphasis. JB Lippincott, Philadelphia.
12. Lesk MR, Ammann H, Marcil G, Vinet B, Lamer B & Sebag M (1993): The penetration of oral ciprofloxacin into the aqueous humor, vitreous and subretinal fluid of humans. Am J Ophthalmol 115: 623-628.
13. McDermont ML, Tran TD, Cowden JW & Bugge CJL (1993): Corneal stromal penetration of topical ciprofloxacin in humans. Ophthalmol 100: 197-200.
14. Monk JP & Campoli-Richards DM (1987): Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 33: 346-391.
15. Mounier M, Adenis JP & Denis F (1988): Ciprofloxacin levels in human eye after intravenous and oral administration. Path Biol 36: 650-652.
16. Neu HC (1991): Microbiologic aspects of fluoroquinolons. Am J Ophthalmol 112: 15S-24S.